Article

Biological variation estimates of Alzheimer’s disease plasma biomarkers in healthy individuals

2023-08-13

Abstract excerpt

<h4>Introduction</h4> Blood biomarkers have proven useful in Alzheimer’s disease (AD), but little is known about their biological variation (BV), which plays a crucial role in the interpretation of individual patient data. <h4>Methods</h4> We measured plasma amyloid-β (Aβ42, Aβ40), phosphorylated tau (p-tau181, p-tau217, p-tau231), glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) in fast...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bb01bcdb-8b7f-5931-b875-8de1f37a7c04
DOI: 10.1101/2023.08.09.23293841

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Biological variation estimates of Alzheimer’s disease plasma biomarkers in healthy individualsDOI 10.1101/2023.08.09.23293841Read

Test‐retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction modelsSemantic proximity Read

Population-based reference equations and Z-scores for blood biomarkers of neurodegenerative diseasesSemantic proximity Read

Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real‐world population‐based cohortSemantic proximity Read

The Alzheimers Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin studySemantic proximity Read

Robustness of plasma p-Tau217 diagnostic thresholds for Alzheimer’s disease across various clinical populations and laboratory environmentsSemantic proximity Read

Genetic architecture of Alzheimer’s disease-related plasma biomarkersSemantic proximity Read

A plasma biomarker panel for detecting early amyloid-β accumulation and its changes in middle-aged cognitively unimpaired individuals at risk for Alzheimer’s diseaseSemantic proximity Read

Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer’s Disease patients and cognitively normal individualsSemantic proximity Read

Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s diseaseSemantic proximity Read

Variability of CSF Alzheimer’s Disease Biomarkers: Implications for Clinical PracticeSemantic proximity Read

Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseasesSemantic proximity Read

Plasma biomarker profiles in autosomal dominant Alzheimer’s diseaseSemantic proximity Read